We can support your drug substance process development efforts at any stage, from early stage to commercialization. We can help your team with the design, planning, execution, analysis, and documentation of experiments, initial and final process risk assessments, QbD studies, development of mechanistic and statistical models and the preparation of source documents for process specific sections in Investigational New Drug Applications (INDs), IND amendments, and New drug Applications (NDAs).